Abstract 3638: AMX-168, a long-acting, tumor protease-sensitive bispecific precursor for the treatment of solid malignancies
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-3638
Abstract: Bispecific T cell engagers (BiTE®) recruit highly cytotoxic host CD3+ T cells for destruction of tumor antigen-specific malignant cells. Bearing a defined single-chain antibody fragment (scFv) binding to CD3 on T cells and a selected… read more here.
Keywords: protease; amx 168; long acting; bispecific ... See more keywords